• Tauroursodeoxycholic Acid: Reading ER Stress

  2026-08-15

  Tauroursodeoxycholic Acid (TUDCA) is more than a general cytoprotective reagent. This article explains how to use TUDCA as a mechanistic perturbation for separating ER stress, neuroinflammation, mitochondrial injury, and apoptosis in disease-model assays.

• Isoproterenol Sulfate Dihydrate for Cell Assays

  2026-08-14

  A scenario-driven guide to using Isoproterenol sulfate dihydrate (SKU C6402) in cell viability, proliferation, cytotoxicity, and human cardiac signaling studies. It connects formulation data, preparation choices, beta-adrenergic biology, and assay interpretation to improve experimental consistency.

• Gepotidacin: Mechanism, Evidence & Research Use

  2026-08-14

  Gepotidacin, also known as GSK2140944, is a first-in-class triazaacenaphthylene antibacterial that inhibits bacterial DNA gyrase and topoisomerase IV. Its dual-target mechanism supports antibacterial research and antibiotic resistance research, but product assay values and clinical-development regimens must not be interpreted as approved medical instructions.

• AG-126 for ERK Pathway and Circuit Research

  2026-08-13

  AG-126 (Tyrphostin AG-126) provides a pharmacological way to test ERK1/2 phosphorylation in neuronal, inflammatory, and ex vivo systems. Its strongest use is as a mechanistic probe: pair pathway inhibition with cell-specific, electrophysiological, cytokine, and behavioral readouts rather than treating it as a stand-alone therapeutic candidate.

• Machine Learning Discovery of Senolytics

  2026-08-13

  The reference study presents a machine-learning workflow trained exclusively on published screening data to identify senolytic compounds despite limited and heterogeneous evidence. Computational screening followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, demonstrating a lower-cost route for early-stage senolytic discovery while highlighting important issues of cell-type specificity and biological validation.

• Triacetin in Brinzolamide Nanoemulsions

  2026-08-12

  The reference study examined brinzolamide-loaded nanoemulsions as a way to improve transcorneal delivery while integrating retinal cell viability and ocular irritation testing. Its key contribution was to connect permeation performance with orthogonal safety screens, identifying formulations and excipients that merit further investigation rather than assuming that enhanced penetration alone indicates ophthalmic suitability.

• ZK53: Human Mitochondrial ClpP Activator Guide

  2026-08-12

  ZK53 gives researchers a selective way to activate human mitochondrial ClpP and connect protease engagement with oxidative phosphorylation failure, DNA-damage signaling, and ferroptosis sensitivity. This guide translates biochemical, cellular, and xenograft evidence into practical workflows and troubleshooting strategies.

• Hexetidine (NSC-17764) Biofilm Resistance on PVC

  2026-08-11

  A 2001 Biomaterials study linked the maturation of PVC-associated biofilm with increasing antimicrobial resistance, using atomic force microscopy and time-dependent killing assays. Its central finding was that Hexetidine was more active than ceftazidime against established biofilms of Staphylococcus aureus and Pseudomonas aeruginosa, although the work remains an in vitro medical-device model rather than a clinical treatment study.

• Intestinal TM6SF2 and MASH: Gut–Liver Mechanisms

  2026-08-10

  A 2025 Nature Metabolism study shows that intestinal TM6SF2 protects against MASH by preserving epithelial barrier function and constraining lipid-driven microbiota and liver signaling. Its conditional mouse models, fecal-transfer experiments, and pharmacological validation identify LPA signaling as a gut–liver mechanism with potential relevance for future MASH research.

• Fasting, eIF4E Phosphorylation, and Tumor Metabolism

  2026-08-09

  The Nature study by Yang and colleagues shows that fasting suppresses overall hepatic translation while selectively increasing translation of mRNAs required for fatty-acid catabolism and ketogenesis. Its central advance is identification of a fatty-acid–AMPK–MNK–phosphorylated eIF4E axis that links dietary state to translational control and creates a metabolic vulnerability in pancreatic cancer.

• MMP-Responsive Hydrogel for Fibrous Dysplasia

  2026-08-08

  This study introduces an injectable hyaluronic acid hydrogel containing triglycerol monostearate nanoparticles for lesion-responsive delivery of the RANKL inhibitor AS2676293 in fibrous dysplasia. By coupling local retention with matrix metalloproteinase-triggered release, the platform reduced lesion progression and improved bone microarchitecture in a GNASR201C knock-in mouse model while offering a strategy to limit systemic exposure.

• SAR405: A Selective Vps34 Inhibitor Workflow

  2026-08-07

  SAR405 enables focused interrogation of Vps34-dependent PtdIns3P production, autophagosome formation, and lysosomal organization without the broad PI3K or mTOR activity that can complicate interpretation. This practical guide combines GFP-FYVE and GFP-LC3 imaging, energy-stress experiments, combination testing, and troubleshooting for reproducible autophagy and vesicle-trafficking studies.

• Intravesical p21 mRNA-LNP Therapy: Mechanistic and Translati

  2026-08-07

  This study introduces a non-viral intravesical delivery method for p21 mRNA-loaded lipid nanoparticles as a tumor suppressor replacement strategy in bladder cancer. The approach demonstrates effective restoration of p21 expression and tumor growth suppression, providing a new model for localized mRNA therapy in oncology.

• Leptin (116-130), amide, mouse: Reliable Tools for Obesity R

  2026-08-06

  This article provides an evidence-based guide for life science researchers and lab professionals using Leptin (116-130), amide, mouse (SKU A1024). By addressing real-world workflow and assay challenges, it demonstrates how this adipocyte-derived hormone fragment enhances reproducibility, sensitivity, and cross-domain research in obesity, diabetes, and immunometabolic studies. The content synthesizes scenario-driven insights, literature context, and practical protocol guidance for advanced laboratory applications.

• Adenosine Triphosphate in Metabolic Research: Protocols & In

  2026-08-06

  Harnessing Adenosine Triphosphate (ATP) from APExBIO enables precise control over metabolic and signaling pathways in advanced cell assays. This article provides actionable workflows, data-backed troubleshooting, and expert guidance for leveraging ATP's full experimental potential.

453 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page